Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
Abada YS, Schreiber R, Ellenbroek B. Abada YS, et al. Among authors: ellenbroek b. Behav Brain Res. 2013 Feb 1;238:243-51. doi: 10.1016/j.bbr.2012.10.039. Epub 2012 Oct 30. Behav Brain Res. 2013. PMID: 23123142
Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease.
Abada YS, Nguyen HP, Ellenbroek B, Schreiber R. Abada YS, et al. Among authors: ellenbroek b. PLoS One. 2013 Nov 1;8(11):e71633. doi: 10.1371/journal.pone.0071633. eCollection 2013. PLoS One. 2013. PMID: 24223692 Free PMC article.
Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.
Abada YS, Nguyen HP, Schreiber R, Ellenbroek B. Abada YS, et al. Among authors: ellenbroek b. PLoS One. 2013 Jul 11;8(7):e68584. doi: 10.1371/journal.pone.0068584. Print 2013. PLoS One. 2013. PMID: 23874679 Free PMC article.
Of rodents and men: understanding the emergence of motor and cognitive symptoms in Huntington disease.
Abada YS, Ellenbroek BA. Abada YS, et al. Behav Pharmacol. 2016 Aug;27(5):403-14. doi: 10.1097/FBP.0000000000000217. Behav Pharmacol. 2016. PMID: 26886208 Review.
Finding the right motivation: genotype-dependent differences in effective reinforcements for spatial learning.
Youn J, Ellenbroek BA, van Eck I, Roubos S, Verhage M, Stiedl O. Youn J, et al. Behav Brain Res. 2012 Jan 15;226(2):397-403. doi: 10.1016/j.bbr.2011.09.034. Epub 2011 Sep 29. Behav Brain Res. 2012. PMID: 21971014
Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit.
Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, Van der Zee CE. Streijger F, et al. Among authors: ellenbroek ba. Behav Brain Res. 2005 Feb 28;157(2):219-34. doi: 10.1016/j.bbr.2004.07.002. Behav Brain Res. 2005. PMID: 15639173
The development of various somatic markers is retarded in an animal model for schizophrenia, namely apomorphine-susceptible rats.
Degen SB, Ellenbroek BA, Wiegant VM, Cools AR. Degen SB, et al. Among authors: ellenbroek ba. Behav Brain Res. 2005 Feb 28;157(2):369-77. doi: 10.1016/j.bbr.2004.08.002. Behav Brain Res. 2005. PMID: 15639188
Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in novelty-induced changes in hippocampal dynorphin B expression and two-way active avoidance: a new key in the search for the role of the hippocampal-accumbens axis.
Cools AR, Dierx J, Coenders C, Heeren D, Ried S, Jenks BG, Ellenbroek B. Cools AR, et al. Among authors: ellenbroek b. Behav Brain Res. 1993 Jun 30;55(2):213-21. doi: 10.1016/0166-4328(93)90117-9. Behav Brain Res. 1993. PMID: 8102850
The behavioural pharmacology of stress.
Willner P, Bergman J, Vanderschuren L, Ellenbroek B. Willner P, et al. Among authors: ellenbroek b. Behav Pharmacol. 2014 Sep;25(5-6):337-9. doi: 10.1097/FBP.0000000000000082. Behav Pharmacol. 2014. PMID: 25083566 No abstract available.
Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
Ellenbroek BA, Ghiabi B. Ellenbroek BA, et al. Curr Pharm Des. 2015;21(26):3760-70. doi: 10.2174/1381612821666150605105325. Curr Pharm Des. 2015. PMID: 26044979 Review.
157 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback